600664 哈药股份
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)7.0298.73311.38010.129-24.120
总资产报酬率 ROA (%)2.4222.8703.5403.006-8.852
投入资产回报率 ROIC (%)3.9524.7745.9495.068-15.179

边际利润分析
销售毛利率 (%)29.23826.21424.66623.71521.759
营业利润率 (%)5.8464.2685.0395.018-8.733
息税前利润/营业总收入 (%)5.9314.3885.5675.668-8.510
净利润/营业总收入 (%)4.4603.0683.7093.201-9.689

收益指标分析
经营活动净收益/利润总额(%)98.26499.74275.19065.96975.838
价值变动净收益/利润总额(%)2.7230.6895.7510.135-3.653
营业外收支净额/利润总额(%)-1.386-1.3970.763-1.8842.740

偿债能力分析
流动比率 (X)1.3211.2611.1951.1121.069
速动比率 (X)1.0771.0280.9690.8490.814
资产负债率 (%)59.51961.57363.18165.57966.334
带息债务/全部投入资本 (%)37.82440.23139.95742.922--
股东权益/带息债务 (%)151.892136.601136.023116.798116.937
股东权益/负债合计 (%)59.53654.36750.98545.68144.276
利息保障倍数 (X)36.16924.47211.3717.632-18.177

营运能力分析
应收账款周转天数 (天)99.53599.228104.846105.9100.000
存货周转天数 (天)60.57058.84566.92872.3520.000